首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Frontiers in oncology

缩写:FRONT ONCOL

ISSN:2234-943X

e-ISSN:2234-943X

IF/分区:3.3/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引33059
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jiannan Sun,Lijun Xu,Yiyin Cao et al. Jiannan Sun et al.
Objective: This study aimed to evaluate the reliability and responsiveness of the SF-6Dv2, and to provide the first comparative assessment of its validity against the EQ-5D-5L in Chinese patients with colorectal cancer (C...
Fengbo Huang,Jing Zhao,Jie Lian et al. Fengbo Huang et al.
Breast secretory carcinoma (BSC) is a rare low-grade malignancy that frequently exhibits the ETV6::NTRK3 fusion gene and rarely presents with distant metastasis. In this report, we describe a case of 72-year-old female diagnosed with BSC, w...
Yi-Ling Li,Xin Sun,Ming-Zhu Ye et al. Yi-Ling Li et al.
Background: Vascular invasion is a hallmark of low-grade endometrial stromal sarcoma (LG-ESS), typically presenting a tumor thrombus within the parametrial vessels. However, extension of tumor thrombus into major vessels ...
Liang Guo,Jing Wang,Xiang Li et al. Liang Guo et al.
Phyllodes tumor (PT) of the breast is a rare fibroepithelial tumor characterized by the proliferation of both epithelial and stromal components. The presence of osteosarcomatous differentiation within the sarcomatous stroma is exceptionally...
Zhuohao Huang,Jinmei Li,Haiyin Ye et al. Zhuohao Huang et al.
Objective: In treatment-naïve patients with EGFR-mutated non-small-cell lung cancer (NSCLC) complicated by malignant pleural effusion (MPE), we first investigated whether the addition of intrathoracic chemotherapy (ICT) ...
Hongfeng Wang,Jianbin Chen Hongfeng Wang
Multiple myeloma (MM) is a common hematologic malignancy characterized by clonal plasma cell proliferation. Despite significant therapeutic advancements with proteasome inhibitors, immunomodulatory drugs, and anti-B-cell maturation antigen ...
Siyu Cheng,Huihong Wu,Wenguang Bao et al. Siyu Cheng et al.
Currently, there is no definitive and effective treatment strategy for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL). In recent years, studies on brentuximab vedotin (BV) and programmed cell death-1 (PD-1) monotherapy for R/...
Diego Mellado,Leondry Mayeta-Revilla,Julio Sotelo et al. Diego Mellado et al.
Introduction: Early detection of breast cancer via mammography screening is essential to improve survival outcomes, particularly in low-resource settings such as the global south where diagnostic accessibility remains lim...
Jiayu Guan,Fuping Li,Wenbin Zhou Jiayu Guan
Background: Breast cancer metastasis remains a major oncology challenge, with circulating tumor cells (CTCs) driving dissemination and multidrug resistance (MDR) hindering treatment efficacy. MRP2, an ABC transporter link...
Xueqin Hou,Zhiming Li,Yibin Liu et al. Xueqin Hou et al.
Objective: Benign and malignant breast tumors exhibit distinct microvascular morphological patterns and spatial distribution characteristics; however, current clinical imaging modalities cannot comprehensively assess thei...